Chicago workers to protest as pension crisis brews

Chicago teachers, shown during a 2012 protest, are among thousands of city workers expected to rally at the state capitol Wednesday against possible pension cuts.

NEW YORK (CNNMoney) More than 1,000 current and retired Chicago teachers, police officers and other city workers are expected to rally at the state capitol Wednesday to fight possible cuts to their retirement benefits amid the city's brewing pension crisis.

After years of avoiding the issue, the city of Chicago is facing a massive spike in its annual bill for the pensions it promised current and retired workers. Next year, the city's required contribution will more than double to $1.07 billion.

Ultimate Guide to Retirement Getting started401(k)s & company plansInvestingAnnuitiesIRAsSelf-employment plansPensions and benefit plansSocial SecurityInsuranceEstate planningLiving in retirementGetting help

City Hall says the nearly $600 million increase translates to the city's annual cost for 4,300 police officers or more than 3,750 firefighters or the resurfacing of nearly 16,000 city blocks.

At the same time, Chicago Public Schools, which have a separate budgeting process, have their own pension fight. The district will pay $613 million towards its teachers' pensions this year-- a big increase from prior years and more than 10% of the agency's total budget.

While the city and school district have to pay the pension bills, only state lawmakers have the authority to change pension benefits.

Lawmakers have already pared back the benefits given to newly-hired workers. Now Democratic Mayor Rahm Emanuel and state legislators say more needs to be done to address "the biggest financial threat our city and school system have ever seen." Here's what's at stake:

Retired and current city workers, who typically don't receive Social Security benefits, could face pension cuts. Residents could receive higher tax bills. City services, already hit by the recession, could be cut even further. Teachers could be laid off and class sizes could increase.

A newly formed coalition of city unions called We Are One Chicago is arguing that retirees rely on their pensions, noting that they don't qualify for Social Security benefits. They argue that workers earn their benefits through significant contributions out of each paycheck and shouldn't pay the price for years of neglect by politicians.

Instead, the coalition proposes eliminating corporate tax subsidies, increasing income taxes for higher earners and raising the city's property tax rate, among other fixes.

"The fiscal problems Chicago faces cannot be solved solely by slashing modest pensions," the group said in a statement. "It will take a serious commitment of new revenue."

Why pension bills are spiking: Chicago is home to one of the most troubled pension systems in ! the country. In total, the city's four pension funds, for firefighters, police officers, and two for other city workers face funding holes of nearly $20 billion. Meanwhile, the teacher's pension fund has its own $8 billion shortfall.

In other terms, city pension funds have set side only 36% of the money they need to pay future obligations. The teachers' fund has just over half. In contrast, a healthy pension fund should have a so-called funding ratio of at least 80%.

It wasn't always like this. The dot com bust and 2008 financial crisis hit the pension funds with significant investment losses, while lawmakers have approved benefit increases that added to the bill.

At the same time, the city and school district have been underpaying into the funds for years. Now, the agencies are required by state law to make the larger pension payments in an effort to return the various pension funds to solvency.

What's at stake for workers: Lawmakers have already approved pension cuts for state workers. Now Chicago employee unions are launching a preemptive against similar cuts being applied to city workers.

As part of a landmark pension overhaul for state workers, Illinois lawmakers in December voted to reduce annual cost-of-living increases for retirees, raise the retirement age for workers 45 and under and cap pensions for the highest-paid workers. The cuts are currently being challenged in court.

One of the law's biggest changes would reduce the annual cost of living increases received by retirees, significantly slowing the growth of pension checks each year. If the same change was applied to Chicago teachers' pensions, for example, retirees could see their retirement income cut by at least 10% over two decades, according to We Are One Chicago.

Top Consumer Service Stocks To Invest In Right Now

According to the coalition, the average r! etiree cu! rrently receives just over $40,000 in annual pension benefits.

Still, many retirees receive healthier checks. Retired firefighters, for example, received average benefits of more than $60,000 in 2012.

Yet other retirees already live on minimal benefits. "It is extremely difficult on the little I get now," said 81-year-old retired Chicago Department of Health worker Louise Bates-Spencer, who retired more than a decade ago and received around $18,000 in pension benefits last year.

What's at stake for residents: Without a pension overhaul, city and state leaders say residents could face tax hikes, gutted city services and larger class sizes in city schools.

Without service cuts, the city would have to bring in close to double the roughly $800 million it currently receives in property taxes, according to city documents.

"The resolution to this crisis must provide a secure retirement for them and retirees, while also looking out for taxpayers and homeowners who are working to make ends meet," Emanuel said in a statement. "We need a balanced approach."

Program note: Follow the real-life drama as Chicago looks to unite at a critical moment in the city's history. CNN Original Series "Chicagoland" airs Thursday nights, starting March 6 at 10/9c.

Top 10 Long Term Companies For 2015

Top 10 Long Term Companies For 2015: Graham Holdings Co (GHC)

Graham Holdings Company, formerly The Washington Post Company, incorporated on July 21, 2003, is a diversified education and media company whose principal operations include educational services, television broadcasting, cable television systems, and online, print and local TV news. The Company owns Kaplan, a provider of educational services to individuals, schools and businesses, serving over one million students annually with operations in more than 30 countries. Its programs include higher education, test preparation, language instruction and professional training. Its Post-Newsweek Stations, Inc owns six television stations which include WDIV-Detroit (NBC), KPRC-Houston (NBC),WPLG-Miami (ABC), WKMG-Orlando (CBS), KSAT-San Antonio (ABC) and WJXT-Jacksonville (independent). The stations also broadcast digital channels focusing on classic television and lifestyle programming, in addition to operating websites, mobile sites and mobile apps delivering breaking news, weather and community news. Its Cable ONE, headquartered in Phoenix, AZ, serves small-city subscribers in 19 midwestern, western and southern states. Cable ONE provides digital video, Internet and phone service to homes and businesses. The Companys Slate Group is a daily online magazine that offers fresh angles on stories in the news and entertainment coverage, all with its signature wit and irreverence, publishing provocative commentary on topics such as politics, culture, business and technology. Slate V is a daily online video magazine offering original video about politics, culture, and business, technology.

The Company divested its interest in Avenue100 Media Solutions Inc., a digital marketing company headquartered in Woburn, Massachusetts, in 2012. The Company sold its interest in the Bowater Mersey Paper Company Limited to the Province of Nova Scotia in 2012. In March 2013, the Company announced it has completed the sale of The Herald, a daily and! Sunday new spaper and its other print and online products to Sound Publishing, Inc.

Education

Kaplan, Inc., a subsidiary of the Company, provides a range of education and related services worldwide for students and professionals. Kaplan conducts its operations through three segments: Kaplan Higher Education, Kaplan Test Preparation and Kaplan International. Kaplan Higher Education (KHE) provides a wide array of certificate, diploma and degree programs on campus and online designed to meet the needs of students seeking to advance their education and career goals. During the year ended December 31, 2012, Kaplans United States-based KHE division businesses include Kaplan University and KHE Campuses.

Kaplan University specializes in online education, is accredited by the Higher Learning Commission of the North Central Association of Colleges and Schools and holds other programmatic accreditations. Kaplan Universitys programs are offered online, while some are offered in a traditional classroom format at 12 campuses in Iowa, Maine, Maryland and Nebraska, and four Kaplan University Learning Centers in four additional states. Kaplan University also includes Concord Law School, a fully online law school. During 2012, Kaplan University had approximately 38,800 students enrolled in online programs and approximately 5,600 students enrolled in its classroom-based programs.

Also residing within Kaplan University is the School of Professional and Continuing Education (PACE). PACE offers a range of education solutions to assist professionals in advancing their careers by obtaining professional licenses, designations and certifications. This includes solutions for insurance, securities, real estate, mortgage and appraisal licensing exams and for advanced designations, such as CFA and CPA exams. PACE serves more than 2,900 business-to-business clients, including more than 70 Fortune 500 companies. In 2012, approxim ately 510,000 students used PACE's exam preparati! on offeri! ngs. As of December 31, 2012, the KHE Campuses business consists of 59 schools in 17 states, which provides classroom-based instruction to approximately 21,100 students.

Kaplan International operates businesses in Europe and the Asia Pacific region. In Europe, Kaplan operates in the businesses, which are all based in the United Kingdom and Ireland: Kaplan UK, Kaplan International Colleges (KIC) and a set of higher education institutions. The Kaplan United Kingdom business in Europe is a provider of training, test preparation services and degrees for accounting and financial services professionals, including those studying for ACCA, CIMA and ICAEW qualifications. In addition, Kaplan United Kingdom provides legal and professional training, including the operation of a United Kingdom law school in collaboration with Nottingham Trent Universitys Nottingham Law School. In 2012, Kaplan United Kingdom provide d courses to approximately 66,000 students, of whom 49,000 were dedicated to accounting and financial services coursework.

The KIC business consists of university pathways business and an English-language training business. The university pathways business offers academic preparation programs especially designed for international students who wish to study in English-speaking countries. KIC operates university pathways programs in collaboration with nine U.K. universities. As of December 31, 2012, KICs university pathways business was serving approximately 2,700 students. The English-language business (previously operated as Kaplan Aspect) provides English-language training, academic preparation programs and test preparation for English proficiency exams, principally for students wishing to study and travel in English-speaking countries. KIC operates a total of 41 English-language schools, with 19 located in the United Kingdom, Ireland, Australia, New Zealand and Canada, and 22 located in the United States, where they operate under the name Kaplan International Centers. During! 2012, th! e English-language business served approximately 65,000 students.

Kaplan also operates three higher education institutions in Europe, located in the United Kingdom and Ireland. These institutions are Dublin Business School, Holborn College and Kaplan Open Learning. As of December 31, 2012, these institutions enrolled an aggregate of approximately 6,500 students. In the Asia Pacific region, Kaplan operates businesses in Singapore, Australia, Hong Kong and China. In Singapore, Kaplan operates three business units, Higher Education, Financial and Professional, which serve more than 16,700 students from various countries throughout Asia.

Kaplan Singapores Higher Education business provides students with the opportunity to earn bachelors and postgraduate degrees in various fields on either a part-time or full-time basis. Kaplan Singapores students receive degrees from affiliated educational institutions in Australia, the U.K. and the U.S. In addition, this division offers pre-university and diploma programs. Kaplan Singapores Financial business provides preparatory courses for professional qualifications in accountancy and finance, such as the Association of Chartered Certified Accountants (ACCA) and the Chartered Financial Analyst (CFA).

In Australia, Kaplan delivers a broad range of financial services education and professional development courses. In 2012, this business provided courses to approximately 17,400 students through classroom programs and to more than 44,800 students through distance-learning programs. In 2012, Kaplan Australia underwent operational restructuring and offers its programs through three business units: English Language and Pathways; Vocational Education; and Higher Education.

The Vocational Education business of Kaplan Australia inc ludes Kaplan Professional Education (KPE), Carrick Education Group and Franklyn Scholar. KPE offers financial services education programs and continuing professional development courses primarily t! o a busin! ess-to-business market, including banks and numerous industry sectors. Approximately 43,000 students are taught through KPE each year. Carrick has traditionally offered English-language programs, vocational training and higher education courses in Australia. Kaplan is evaluating various strategic alternatives with respect to the Carrick business lines. As of December 31, 2012, Carrick was providing services to approximately 1,300 students. Franklyn Scholar offers a wide range of custom-developed programs to business clients. More than 16,000 students are taught through Franklyn Scholar each year.

The higher education business of Kaplan Australia comprises Kaplan Online Higher Education (KOHE) and Kaplan Business School (KBS), which offers diploma, bachelors and masters degree programs. As of December 31, 2012, KBS has opened a new school in Brisbane and operates in four states in Australia teaching approximately 700 students each year. KOHE teaches approximately 1,800 students annually in postgraduate courses primarily in the financial services sector.

In Hong Kong, Kaplan offers a comprehensive array of programs, ranging from language education and standardized test preparation to corporate and financial training and higher education degree courses. During 2012, Kaplans Hong Kong business provided courses to more than 15,700 students.

In China, Kaplan provides foundation programs to Chinese students through partnerships with prestigious Chinese universities and high schools. Kaplan China offers foundation programs at 11 campuses and had more than 1,100 students enrolled at the end of 2012. Kaplan China also cooperates with several Chinese universities to provide ACCA training programs to the s tudents. Cable ONE offers broadband Internet access service on virtually all of its cable systems and is the sole Internet service provider on those systems.

Kaplan International also includes the Kaplan Global Solutions business unit, which continues to dev! elop part! nerships with colleges, universities and non-profit corporations and foundations. Kaplan Global Solutions, through its Colloquy business, enables its university partners to develop online educational programs by providing an array of research, marketing and design services. Through its Global Pathways programs, Kaplan Global Solutions enables its partner institutions in the Americas to enhance their brand globally and increase international student enrollments by designing and marketing custom programs aimed at student success.

Cable Television Operations

Through its subsidiary Cable One, Inc. (Cable ONE), the Company owns and operates cable television systems that provide v ideo, Internet and voice service to subscribers in 19 midwestern, western and southern states. At the end of 2012, Cable ONE provided cable service to approximately 593,600 video subscribers, representing about 41% of the 1,439,740 homes passed by the systems, had approximately 459,200 subscriptions to high-speed data (HSD) service and 184,500 subscriptions to VoIP (digital voice) service. The video services offered by Cable ONE include certain premium, cable network and local over-the-air channels in high-definition television (HDTV) format. Cable ONE offers voice over Internet Protocol service, which permits users to make voice calls over broadband communications networks, including the Internet.

Other Activities

WaPo Labs is a digital team focusing on experimenting with emerging technologies. In 2012, WaPo Labs launched several projects in partnership with the Companys media properties: Personal Post, a feature on washingtonpost.com that deliv ers personalized article recommendations based on a users interests and past reading behavior; The Fold, a video news program available on washingtonpost.com, Google TV and Android tablets, and The Root 100, which comprises 100 Android apps aggregating content about the Root 100 honorees, chosen for their impact and influence within the ! African-A! merican community. In addition to working closely with the Companys news websites, WaPo Labs oversees Washington Post Social Reader (Social Reader) and Trove. Social Reader is a Facebook-connected Website that delivers news articles based on a users interests and what their friends are reading. Social Reader aggregates content from the Post, Slate, Foreign Policy, Express, the Root and more than 90 other content partners to create a social stream of articles.

Social Code LLC (Social Code) is a marketing solutions company helping Fortune 500 brands maximize their marketing efforts on social media platforms. Celti c Healthcare, Inc. (Celtic) is a Medicare-certified provider of home health and hospice services headquartered in Mars, PA. Through its subsidiaries, Celtic is licensed to provide home health and hospice services throughout Pennsylvania and Maryland. These services include skilled nursing, physical therapy, occupational therapy, speech therapy, social work, nutrition, chaplain and aid services. In addition, Celtic provides virtual care services to patients throughout its service territories. Celtic derives 74% of its revenue from Medicare, with the remaining sources of revenue being Medicaid, commercial insurance and private payors.

The Company competes with Edmunds.com, AutoTrader.com, Realtor.com, Zillow.com, Yelp, OpenTable, Google, Monster.com, CareerBuilder.com and Yahoo!.

Advisors' Opinion:

• [By Paul Ausick]

  Kaplan booked more than $2 billion in revenues in 2013, down slightly from 2012. Kaplan is owned by Graham Holdings Co. (NYSE: GHC), which was spun out of the Washington Post Co. when Jeff Bezos, CEO of Amazon.com Inc. (NASDAQ: AMZN) bought the newspaper last year

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-10-long-term-companies-for-2015.html

Is bull market morphing into Fed-driven bubble?

NEW YORK — Is the great stock market rally of 2013, which has been turbocharged by the Federal Reserve's easy-money policies, a boom to be savored — or a bubble to be feared?

The bubble debate has become increasingly murky in recent weeks as more of the traditional financial fingerprints Wall Street uses to identify a frothy market show up on investors' radar.

A growing chorus of Wall Street pros say a bubble is forming in the U.S. stock market. They blame the Fed's unprecedented stimulus, including its $85 billion in monthly bond purchases, for artificially inflating stock prices. There is concern that if the Fed does not dial back its asset purchases soon, stocks could shoot higher and become even more delinked from business fundamentals.

The Fed said this week that it would continue its asset purchases at the current level, once again delaying the inevitable tapering of a program designed to stimulate the economy by keeping interest rates low. The policy, however, has pushed rates so low that a lot of the $1 trillion the Fed is injecting into markets annually has made its way into the stock market.

"We believe a bubble is developing in stocks," says Patrick Adams, portfolio manager at PVG Asset Management. "Fed policy is forcing money into (stocks), pushing forward returns that would have come in future years. There are clear excesses. "

Signs of exuberance abound. The Dow Jones industrials and Standard & Poor's 500 are setting records at a pace not seen since 1999. And the year-to-date gains are huge. In a flashback to the 1990's dot-com stock craze, the Nasdaq composite is up almost 30%.

Top 10 Long Term Stocks To Watch Right Now

Similarly, the S&P 500's current price-to-earnings ratio, a gauge of how pricey stocks are, has ticked up as high as 16.7, says Bespoke Investment Group. That's the highest in a year and close to the 17-plus level seen near the! market's last top in 2007, Thomson Reuters says. In another sign of optimism, Main Street investors who say they are "bearish," or think stocks will fall, recently fell to less than 18%, its lowest since January 2012, says the American Association of Individual Investors.

"There's no bubble yet," although the potential for one is there, counters Rod Smyth, chief investment strategist at Riverfront Investment Group. "It's hard to say stocks are in a bubble when you look at the pace of earnings." He says stocks are simply getting back to fair value after a steep drop and reflect an improving global economy. The S&P 500 is up just 12% from its 2007 high while corporate earnings have nearly doubled since 2009, Smyth says.

"The bubble could get bigger," warns Adams. "The Fed looks like it will continue to blow the bubble up a little bit more, which will just make the pain worse on the downside."

10 Best Healthcare Equipment Stocks To Buy Right Now

Don't be surprised, but Hewlett-Packard (NYSE: HPQ  ) is about to get back into the smartphone business, even after a spectacular failure and exit in 2011. Shortly after taking over as CEO, Meg Whitman said it was unlikely that HP would ever be in the smartphone business again, a stance that she backtracked on a year later when she acknowledged that HP has to "ultimately offer a smartphone."

In an interview with The Indian Express, HP's director of consumer devices in the Asia Pacific region, Yam Su Yin, confirmed the re-entry into the smartphone market, although declined to specify when the PC giant would make the move. The exec added, "HP has to be in the game."

She acknowledges that due to prior missteps, HP is awfully late to the smartphone market. Because of that tardiness, HP needs to offer a different value proposition than what's currently available in the market, but there "are still things that can be done" and that HP will offer a "differentiated experience."

Top Retail Stocks To Buy For 2015: Entergy Arkansas Inc (EAA)

Entergy Arkansas, Inc. (Entergy Arkansas) generates, transmits and distributes electric power primarily to retail customers in Arkansas. Entergy Arkansas holds franchises to provide electric service in approximately 307 incorporated cities and towns in Arkansas. On November 30, 2012, the Company purchased a Hot Spring Energy Facility.

The Company owns and operates, through an affiliate, the ANO 1 and ANO 2 nuclear power plants. The Company is a wholly owned subsidiary of Entergy Corporation (Entergy).

Advisors' Opinion:

• [By maarnio]

  Spectral is focused on the development and commercialization of a treatment for severe sepsis utilizing its Endotox in Activity Assay (EAA) and the Toraymyxin therapeutic (PMX). If approved, this will be the first theranostics product, a targeted therapy guided by a specific diagnostic, in the area of sepsis. The company also manufactures and sells certain proprietary reagents.

10 Best Healthcare Equipment Stocks To Buy Right Now: Worthington Industries Inc.(WOR)

Worthington Industries, Inc. operates as a diversified metals processing company focusing on steel processing and manufactured metal products in the United States, Canada, and Europe. It processes flat-rolled steel and stainless steel for the automotive, construction, lawn and garden, hardware, furniture, office equipment, electrical control, tubing, leisure and recreation, appliance, agricultural, HVAC, container, and aerospace markets. The company also produces low-pressure liquefied petroleum gas and refrigerant gas cylinders; high-pressure and industrial/specialty gas cylinders; seamless steel high pressure cylinders for compressed natural gas storage in motor vehicles; aluminum-lined, composite-wrapped high-pressure cylinders; airbrake tanks; and consumer products. In addition, it produces recovery tanks for refrigerant gases; air reservoirs for truck and trailer original equipment manufacturers; and Balloon Time helium kits. Further, the company designs and manufactu res reusable custom platforms, racks, and pallets made of steel for supporting, protecting, and handling products throughout the shipping process; provides framing systems and stairs for mid-rise buildings, and current and past model automotive service stampings; designs, builds, and supplies light gauge steel framed commercial structures and multi-family housing units; supplies and constructs metal framing products for single family housing with a focus on military housing; and manufactures pre-engineered steel egress stair solutions. Worthington Industries was founded in 1955 and is headquartered in Columbus, Ohio.

Advisors' Opinion:

• [By Ben Levisohn]

  Shares of Harsco have gained 4.7% to $26.43 today at 1:16 p.m., outpacing other construction & engineering companies. Dycom (DY) has advanced 0.5% to $30, KBR Inc. (KBR) has ticked up 0.1% to $33.03, Worthington Industries�(WOR) has risen 2.8% to $38.85�and Tutor Perini (TPC) has rallied 3.6% to $22.46.

10 Best Healthcare Equipment Stocks To Buy Right Now: iShares 1-3 Year Credit Bond ETF (CSJ)

iShares Lehman 1-3 Year Credit Bond Fund (the Fund) seeks investment results that correspond to the price and yield performance of the investment-grade credit sector of the United States bond market as defined by the Lehman Brothers 1-3 Year U.S. Credit Index (the Index). The Index measures the performance of investment-grade United States credit securities, corporate debt and sovereign, local authority and non-United States agency bonds that are United States dollar denominated.

The Fund invests in a representative sample of the securities in the Index, which has a similar investment profile as the Index. The Index includes investment grade United States credit securities that have a remaining maturity of greater than or equal to one year and less than three years, and have more than $250 million or more of outstanding face value. Barclays Global Fund Advisors serves as an advisor to the Fund.

Advisors' Opinion:

• [By GURUFOCUS]

  In addition to individual stocks several funds pay a monthly dividend. Below is a sampling of these:
  Monthly Bond Funds- iShares Barclays 1-3 Year Credit Bond (CSJ) | Yield: 1.29%
  - Vanguard Short-Term Bond ETF (BSV) | Yield: 1.25%
  - Vanguard Intermediate-Term Bond ETF (BIV) | Yield: 2.96%
  - Vanguard Long-Term Bond ETF (BLV) | Yield: 4.42%

10 Best Healthcare Equipment Stocks To Buy Right Now: Zulily Inc (ZU)

Zulily, Inc., incorporated on October 16, 2009, is an e-commerce company. The Company, through its desktop and mobile Websites and mobile applications, which it refers to as its sites, helps its customers discover new and unique products. The Company provides moms with a selection of over 4,500 product styles offered on a typical day through various flash sales events, which are limited-time curated online sales of selected products launched each day on its sites. The Company offers merchandise primarily targeted at moms purchasing for their children, themselves and their homes. Its merchandise includes children�� apparel, women�� apparel, and other product categories, such as toys, infant gear, kitchen accessories and home decor The Company sources its merchandise from thousands of vendors, including emerging brands and smaller boutique vendors, as well as larger national brands.The Company offers merchandise primarily targeted at moms purchasing for their children, themselves and their homes. Its merchandise includes children�� apparel, women�� apparel, and other product categories such as toys, infant gear, kitchen accessories and home decor.

Offering for Moms

The Company launches a variety of flash sales event. Typically, these events feature over 4,500 product styles from different vendors and last for 72 hours. The day�� events are kicked off by an early morning e-mail to its email subscribers and push communication to users of its mobile applications offerings are only available for a limited time and in a limited quantity.

Offering for Vendors

The Company�� primary vendors are emerging brands and smaller boutique vendors. These are typically small-to-medium sized businesses, many of which were started by mom entrepreneurs. The Company introduces these vendors to its large audience and help them tell their stories in a way that differentiates their products and properly reflects their brand attributes. Its entire operational infr! astructure-photography studios, editorial writers, fulfillment operations and technology capabilities-is designed to showcase these emerging brands��and smaller boutique vendors��products in the most compelling, engaging and personalized way.

The Company competes with Amazon.com, Target, Toys R Us, Walmart and eBay.

Advisors' Opinion:

• [By Ben Eisen]

  Alongside multiple all-time highs for the S&P 500 (SPX) �and Dow Jones Industrial Average (DJIA) , the dollars attached to Internet startups Zulily Inc. (ZU) � and Snapchat fed talk of ��roth�� ��ubbles��and a redux of the stock-market battering that followed stock peaks in the mid-2000s and late 1990s.

• [By Tess Stynes var popups = dojo.query(".socialByline .popC"); popups.forEach(fu]

  Fast-growing Internet retailer Zulily Inc.(ZU) reported a first-quarter net loss as soaring sales were accompanied by an order backlog that pushed up its expenses and lengthened shipping times. Shares fell 19% to $37.10 premarket.

• [By Rex Crum]

  Other Internet-based stocks rose in the wake of the Priceline-OpenTable deal, with Yelp Inc. (YELP) �up almost 14%, Groupon Inc. (GRPN) �rising nearly 4% and online falsh-deal company Zulily Inc. (ZU) �up by 5%.

10 Best Healthcare Equipment Stocks To Buy Right Now: Melrose Industries PLC (MLSPF)

Melrose Industries PLC acquires manufacturing businesses and improves them. The Company operates in four divisions: Energy, Lifting, Other Industrial and Elster. The Energy division is a supplier of turbogenerators, other electricity generating machinery, switchgear, transformers and power infrastructure equipment. Its products consist of power management and excitation systems; power and system transformers, and aftermarket servicing. Lifting division is a supplier of lifting fittings, blocks and custom engineered material handling products and supplier for wire and wire rope. Other Industrial division has manufacturing businesses across the housing, construction and scrap processing sectors. Elster is a provider of gas control equipment and related communications, gas, electricity and water meters and software solutions. In January 2014, the Company disposed Harris Waste Management Group, Inc. to Avis Industrial Corporation. Advisors' Opinion:

• [By Roland Head]

  Today, I'm going to take a look at�Melrose Industries� (LSE: MRO  ) (NASDAQOTH: MLSPF  ) , an unusual company which specialises in turning around manufacturing businesses, before selling them on. Melrose's current portfolio of businesses contains German utility meter maker Elster, Brush Turbo Generators and Marelli Motori, which make electric motors and generators, and Bridon, which makes rope and wire products used in the oil and gas industry.

10 Best Healthcare Equipment Stocks To Buy Right Now: Oramed Pharmaceuticals Inc (ORMP)

Oramed Pharmaceuticals Inc., incorporated on March 10, 2011, is a development-stage pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet to be used for the treatment of individuals with diabetes, use of orally ingestible capsules, tablets or pills for delivery of other polypeptides. The Company owns oral dosage form drug portfolio, it is, on an on-going basis, considering in-licensing and other means of obtaining additional technologies to complement and/or expand the product portfolio. The Company�� products include ORMD-0801 - Oral Insulin Capsule and ORMD-0901 - Oral Exenatide.

The Company focuses to conduct research and development on the technology covered by the patent application Methods and Composition for Oral Administration of Proteins. Through its research and development efforts, it focuses to develop an oral dosage form that will withstand the chemical environment of the stomach and intestines and will be effective in delivering active insulin for the treatment of diabetes. It intends to conduct the clinical trials to file an Investigational New Drug (IND), application with the United States Food and Drug Administration (FDA). It also focuses to conduct research and development by deploying its drug delivery technology for the delivery of other polypeptides in addition to insulin, and to develop other pharmaceutical products.

Advisors' Opinion:

• [By Lisa Levin]

  Oramed Pharmaceuticals (NASDAQ: ORMP) shares moved up 15.68% to $17.85. The volume of Oramed Pharmaceuticals shares traded was 971% higher than normal. Oramed received patent allowance in Israel, Australia for platform technology in oral delivery of proteins.

• [By Lisa Levin]

  Oramed Pharmaceuticals (NASDAQ: ORMP) shares moved up 21.26% to $14.20. The volume of Oramed Pharmaceuticals shares traded was 621% higher than normal. Oramed shares have jumped 187.01% over the past 52 weeks, while the S&P 500 index has gained 28.75% in the same period.

• [By Ben Levisohn]

  Oramed Pharmaceuticals (ORMP) has dropped 19% to $12.11 after the company said it would sell nearly 1.6 million shares of stock for $10 a share.

  BP plc (BP) has fallen 0.7% to $47.24 after a U.S. judge refused its request to revise the way damages from the Deepwater Horizon oil spill are calculated.

10 Best Healthcare Equipment Stocks To Buy Right Now: BG Group PLC (BRGXF.PK)

BG Group plc (BG Group) is a natural gas company. The Company is engaged in the exploration, development and production of natural gas and oil. It operates in three business segments: Exploration and Production (E&P), Liquefied Natural Gas (LNG) and Transmission and Distribution (T&D). Effective January 1, 2012, the Company was managed across three regions: Americas and Europe; Africa, Central and South Asia, and Australia and East Asia, supported by Global Energy Marketing and Shipping (GEMS) and BG Advance. The Company has interests in 25 countries on five continents. During the year ended December 31, 2011, the Company acquired an interest in, and operatorship of, offshore blocks L10A (BG Group 40%) and L10B (BG Group 45%) in Kenya. During 2011, the Company acquired additional Marcellus shale properties in partnership with EXCO Resources, Inc. (EXCO). In June 2013, BG Group PLC announced that it has completed the sale of its 65.12% holding in Gujarat Gas Company Limited (GGCL). Advisors' Opinion:

• [By Heather Ingrassia]

  On Thursday, August 15, GasLog (GLOG) announced that it had ordered two new 174K cbm Tri-Fuel Diesel Electric LNG carriers from Samsung Heavy Industries. These carriers are expected to be delivered in 2016 which is the same year the company will begin seven-year charters with BG Group (BRGYY.PK) (BRGXF.PK).

Top Wireless Telecom Stocks To Watch Right Now

Top Wireless Telecom Stocks To Watch Right Now: KDDI Corp (KDDIF)

KDDI CORPORATION is a telecommunications company. The Mobile Telecommunication segment is engaged in the provision of mobile communications services, including voice and data services, and mobile WIMAX services, as well as the sale of mobile communication terminals and the provision of contents. The Fixed-line Telecommunication segment provides broadband services, including fiber to the home (FTTH) and cable television (TV) services, as well as domestic and overseas communication services, data center services and information and communication technology (ICT) solution services. The Others segment is involved in the operation of call centers and the development of research and advanced technology. On December 2, 2013, it transferred all shares of a wholly owned subsidiary, JAPAN CABLE NET LIMITED to another subsidiary. In December 2013, the Company acquired the entire share capital in Yugen Kaisha Cosmos. Advisors' Opinion:

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- With the yen holding on to its gains and investors cautious as earnings season kicks off, Japanese stocks slid lower Friday after closing the previous day with some late-session gains. The Nikkei Stock Average (JP:NIK) fell 0.9% to 14,358.28, with the Topix down 0.8%, as the dollar bought 97.36 yen, little changed from 24 hours earlier. The relatively strong yen weighed on some names with high global exposure, as Sharp Corp. (JP:6753) (SHCAF) lost 1%, Pioneer Corp. (JP:6773) (PNCOF) dropped 1.6%, and Bridgestone Corp. (JP:5108) (BRDCF) fell 1.2%. ! An outlook cut from Canon Inc. (JP:7751) (CAJ) helped send its shares down 1%, while rival Nikon Corp. (JP:7731) (NINOF) lost 1.8%, though Olympus Corp. (JP:7733) (OCPNF) gained 1%. Telecoms were weak, with Softbank Corp. (JP:9984) (SFTBF) falling 2.5%, KDDI Corp. (JP:9433) (KDDIF) down 1.7%, and NTT DoCoMo Inc. (JP:9437) (NTDMF)

• [By Daniel Inman]

  In Tokyo, KDDI (JP:9433) (KDDIF) gained 0.6% after the telecommunications company reported a record-high and consensus-beating operating profit for the first half of the fiscal year, due to a stronger-than-expected increase in subscription and a rise in usage revenue.

• [By Daniel Inman]

  In Tokyo, telecoms firm KDDI Corp. (JP:9433) (KDDIF) rose 2% after a Nikkei report said that the firm will likely report a record first-half group operating profit, with a 50% on-year increase. TDK Corp. (JP:6762) (TTDKF) , however, dropped 0.2% after a separate Nikkei report said that the electronics-component producer will report an 8% increase in opera! ting prof! it over the same period.

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Japanese stocks opened sharply higher Monday, with the Nikkei Stock Average (JP:NIK) advancing 1.1% to 14,242.86 after falling 2.8% Friday, as end-of-the-week gains for U.S. shares and some earnings news helped lift the market. The Topix also saw solid gains, up 0.8% in early moves. Major advances included a 2.5% rise for Hitachi Ltd. (JP:6501) (HTHIF) , a 4.1% surge for Mitsubishi Motors Corp. (JP:7211) (MMTOF) , and a 2.6% improvement for KDDI Corp. (JP:9433) (KDDIF) after the Nikkei business daily said the telecom will report a 50% increase for operating profit in the fiscal first half compared to a year earlier. Sony Corp. (JP:6758) (SNE) added 2% after scoring a Credit Suisse upgrade to outperform. Shares of NTT DoCoMo Inc. (JP:9437) (NTDMF) traded 1.1% higher after posting above-forecast quarterly results Friday, while JFE Holdings Inc. (JP:5411) (JFEEF) fell 3.2% after the steel producer also reported earnings.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-wireless-telecom-stocks-to-watch-right-now-2.html

PC Sales Could Increase for Intel

5 Best Semiconductor Stocks To Own Right Now

By John Mylant, founder and CEO of OptionsWeekly.Org

NEW YORK (TheStreet) -- For the last few years, authors including me have been writing about how the PC industry continues to shrink and will fall by the wayside due to technological advances in mobile computing.

Although this trend is certainly hurting chipmakers such as Intel (INTC), it seems our articles may have been premature.

Even though many chipmakers have focused their energies on the mobile market for things like tablets and smartphones, it appears PCs may not be going away like we thought they would. Gus Richard, an analyst at Piper Jaffray, noted a revival in corporate PC buying that will be cycling in April 2014, coinciding with the release of Windows 8.1 in the fourth quarter of this year. Low-end tablets are expected to continue to replace low-end notebooks. On the corporate side, the PC industry is expected to grow. This is good news for Intel, even as it transitions into tablet processors. Intel is launching its "Bay Trail" processor, and it is expected to perform well in tablets and computers. It has been a long time since the company has seen a good shot in the arm like this. Mr. Richard believes we could see Intel's revenue rise after two straight years of decline. This belief would coincide with an event that Intel hosted. An "Intel-sponsored" survey of 3,977 adults from the U.S. was done by the research firm IDC in June. Here's a summary of the results, which were reported by AllThingsD: 1. PCs are considered the "primary" computing device by 97% of respondents. 2. Of that group, more than 41% said they planned to buy a new computer in the next year. 3. PCs are considered extremely important in daily life to these respondents. The were asked what they'd give up first instead of their computer for a week, and 73% said exercise, 71% said candy and sweets, 65% said caffeine and 58% said TV. 4. Respondents said that they typically spent a total 43 hours a week on all types of computing devices. More than half of that time, however, was spent in front of a PC. Bay Trail is expected to be the catalyst that will drive tablet market share toward Intel, with a possible revenue base of $500 million to $1 billion, according to Richard. With the rise in corporate PC buying and the positive results of this survey, there appears to be optimism for Intel right now. It is quite interesting to see how analysts give different perspectives. While Gus Richard of Piper Jaffray upgraded the company to neutral because of the forecasted increase in top-line PCs and Intel's "Bay Trail" processor, another analyst downgraded the company to neutral. Tristan Gerra, a semiconductor analyst for R.W. Baird, cut Intel's rating to neutral from outperform. A number of factors, including a "present" reduction in PC order rates, was given for his reasoning. From his perspective, PC units were expected to decline into the teens this year, and that is a downgrade from the expectations they had earlier this year. He says sales of "consumer" PCs will remain under pressure through 2014 because larger size tablets have been introduced into the market. PC manufacturers have been waiting for a sizable increase in sales of PCs among consumers. Evidently the average home PC is about four years old, and one would think consumers would become frustrated with their slower, older machines and would eventually replace them. This hasn't happened yet, however, as PC sales remain slow. From a consumer perspective, tablets are just easier to use and more mobile than PCs. This is why they have been chosen and purchased over low-end laptops. Media files, photos and other documents are just easier to manage on a tablet than they are on a PC. PCs come out on top when one thinks about productivity or getting something important done; this is why they remain. From one perspective, Intel looks better because "corporate" PC sales are expected to grow. On the other hand, from another's perspective, Intel looks worse because "consumer" PC sales are expected to continue slumping. I guess it's all from what perspective you're coming from. The long-awaited "purchase wave" by consumers of home PCs has not arrived yet, and sales continue to slump. Corporations have not done away with PCs, because they serve an important function for business that tablets just cannot compete with yet. But the big focus should be upon the long-term investment in Intel as it continues to morph into the tablet market with its "They Trail" processor that will transcend both PCs and tablets. At the time of publication, Mylant held no shares of stocks mentioned in this article. This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.

Top Medical Stocks To Invest In Right Now

In 2012, some 58,500 paid, regulated long-term care companies served about 8 million people in the U.S., some 4.7 million of whom received that care in their home. And more often than not, experts say those receiving that care ��be it one, two or all of the basic activities of daily living ��didn't know the first thing about hiring a home health care provider.

So what do you need to know should you ever need the services of a home health care provider?

Get smart

First, knowing whether you need home health care is a good start. Licensed home health aides provide hands-on personal care, but not medical care, in the home ��activities such as bathing and dressing. If all you need is help with cooking and running errands, you might be better off hiring homemaker services, also referred to as personal care assistants or companions.

Top Defensive Companies To Buy For 2015: Biota Pharmaceuticals Inc (BOTA)

Biota Pharmaceuticals, Inc., formerly Nabi Biopharmaceuticals, incorporated on March 14, 1969, is an anti-infective drug development company, with key expertise in respiratory diseases, particularly influenza. Biota developed the neuraminidase inhibitor, zanamivir, subsequently marketed by GlaxoSmithKline as Relenza. The Company�� researches include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections. In addition, Biota and Daiichi Sankyo co-own a range of second generation influenza anti-virals, of which the lead product lnavir, is approved for marketing in Japan.

The Company�� products include Zanamivir, Inavi, Phoslyra, BioStar OIA FLU and BioStar OIA FLU A/B. Zanamivir is a neuraminidase inhibitor for the treatment and prophylaxis of influenza marketed as Relenza by GlaxoSmithKline. Inavi (laninamivir) is a neuraminidase inhibitor marketed by Daiichi Sankyo in Japan. Phoslyra is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). BioStar OIA FLU and BioStar OIA FLU A/B are influenza diagnostic tests, which are marketed by Inverness Medical as part of their BioStar product range.

Relenza is delivered directly to the primary site of infection on the lungs, using a Disk Inhaler device. Relenza is approved in over 50 countries for the treatment of influenza, including in the United States, the European Union, Japan and Australia. Relenza is also approved for use as a preventative (prophylactic) treatment against influenza. Inavir is approved for sale in Japan for the treatment of influenza in adults and children. Daiichi Sankyo has applied to sell Inavir in Japan for the prevention of influenza.

PhosLo and Phoslyra are different dose forms of calcium acetate; a phosphate binder approved in multiple countries for the control of hyperphosphatemia (high serum phosphate) in patients with end stage renal disease (ESRD). PhosLo and Pho! slyra were sold to Fresnius Medical Care. Biota, together with its Japanese based partner, Daiichi Sankyo, have developed an inhaled antiviral compounds for influenza, called long acting inhaled neuraminidase inhibitors (LANI). Biota's human rhinovirus (HRV) drug for the prevention and treatment of the causes of the common cold, BTA798, has completed Phase I, Phase IIa and Phase IIb clinical trials.

Advisors' Opinion:

• [By gurujx]

  Biota Pharmaceuticals Inc (BOTA) Reached the 3-year Low of $2.42

  The prices of Biota Pharmaceuticals Inc (BOTA) shares have declined to close to the 3-year low of $2.42, which is 93.3% off the 3-year high of $34.92.

Top Medical Stocks To Invest In Right Now: Rosetta Genomics Ltd (ROSG)

Rosetta Genomics Ltd., incorporated on March 9, 2000, is seeking to develop and commercialize diagnostic tests based on discovered group of genes known as microRNAs. The Company has established a clinical laboratory improvement amendment (CLIA)-certified laboratory in Philadelphia, which enables it to develop, validate and commercialize its own diagnostic tests applying its microRNA technology. In July 2011, the Company launched its fifth product - miRview lung. As of December 31, 2011, the Company launched five tests based on its five microRNA technologies: miRview mets; miRview mets2; miRview squamous; miRview meso, and miRview lung.

Rimonim Consortium

In January 2011, the Company joined the Rimonim Consortium, which is supported by the Office of the Chief Scientist at the Ministry of Industry, Trade and Labor of the State of Israel, or the OCS. The purpose of the consortium is to develop RNA interference, or RNAi, -based therapeutics.

Rosetta Green

Rosetta Green Ltd. is an Israeli subsidiary of the Company, which was established to leverage its capabilities into the areas of cleantech and plant biotech by using its microRNA technologies to develop plants and algae more suitable for various applications, such as feedstocks for biofuels and agriculture. Research at the Rosetta Green project has been shown to develop algal strains with oil content, to discover potential novel microRNAs from commercially-important algae and to identify drought-regulated microRNAs in plants.

The Company competes with Pathwork Diagnostics, Inc., Biotheranostics, Inc., Combimatrix Corporation, Alnylam Pharmaceuticals, Inc., Asuragen Inc., Exiqon A/S, Life Technologies Corporation, Isis Pharmaceuticals, Merck & Co., Inc., Santaris Pharma A/S, and Regulus Therapeutics.

Advisors' Opinion:

• [By Peter Graham]

  The Q3 2014 earnings report for molecular diagnostic company Myriad Genetics, Inc (NASDAQ: MYGN) is due out after the market closes on Tuesday and things could get ugly since unlike potential diagnostic stock peers such as Rosetta Genomics Ltd (NASDAQ: ROSG) and mid cap diagnostic stock Quest Diagnostics Inc (NYSE: DGX), it�� the most shorted stock on the Nasdaq with short interest of 52.07%. Aside from the Myriad Genetics earnings report, it should be said that Rosetta Genomics Ltd last reported earnings on March 31st and those�earnings were for the full year 2013 while�Quest Diagnostics reported Q1 2014 earnings on April 24th that were a disappointment due to restructuring costs and harsh winter weather. However, Myriad Genetics has been the more interesting stock as Medicare reimbursement rate increases and the lost of a court bid to block competition while a patent-infringement case is pending have sent its shares all over the place.

Top Medical Stocks To Invest In Right Now: Euromedis Groupe SA (EMG)

Euromedis Groupe SA is a France-based company that specializes in the design, manufacture, distribution, rental and export of medical and surgical equipment and products, and services for medical home care for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals. The Company's product portfolio include products, such as syringes and needles; surgical equipment, such as catheters, instrumentation and compresses; gloves; hygiene products, comprising disposable clothing, masks and paper towel products, and pharmaceutical equipment, offering cotton wool and thermometers. Euromedis Groupe SA exports its products to Europe and Africa. Advisors' Opinion:

• [By Sofia Horta e Costa]

  Commodity producers increased as base metals rallied, with BHP Billiton Ltd. (BHP), the largest mining company, climbing 3.7 percent. Man Group (EMG) Plc soared 13 percent on a plan to redeem debt. Royal Bank of Scotland Group Plc dropped by the most in two months after Britain�� biggest state-owned lender reported operating profit that fell short of analysts��estimates.

Top Medical Stocks To Invest In Right Now: Synergy Pharmaceuticals Inc (SGYP)

Synergy Pharmaceuticals, Inc., incorporated on February 11, 1992, is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company�� lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and constipation-predominant-irritable bowel syndrome (IBS-C). It is also developing SP-333, the second generation GC-C receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis (UC). The Company�� active pharmaceutical ingredients (APIs) and the final formulated drug products are manufactured for it by third party contractors.

As of December 31, 2011, the Company was developing plecanatide, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. Plecanatide is an agonist of GC-C receptor. As of December 31, 2011, the Company was dosing patients in an 800-patient Phase II/III clinical trial of plecanatide to treat. It is also developing a second generation GC-C receptor analog, SP-333, which is in pre-clinical development for the treatment of gastrointestinal inflammatory diseases. SP-333 is a synthetic analog of uroguanylin, a natriuretic hormone.

The Company competes with Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.

Advisors' Opinion:

• [By Monica Gerson]

  Breaking news

  Time Warner Cable (NYSE: TWC) reported a drop in its third-quarter profit. Time Warner Cable's quarterly profit fell to $532 million, or $1.84 per share, from $808 million, or $2.60 per share, in the year-ago period. To read the full news, click here. Synergy Pharmaceuticals (NASDAQ: SGYP) today announced the start of a phase 2 clinical trial to evaluate the safety and efficacy of SP-333, its second-generation GC-C agonist and once-daily oral treatment, in adult patients with opioid-induced constipation (OIC). To read the full news, click here. Cigna (NYSE: CI) reported a 19% rise in its third-quarter earnings and lifted its full-year earnings outlook. To read the full news, click here. Charm Communications (NASDAQ: CHRM) announced today that the special committee of the Company's board of directors, consisting of independent directors Mr. Zhan Wang, Mr. Andrew J. Rickards and Mr. Gang Chen, has retained China Renaissance Securities (Hong Kong) Limited as its financial advisor and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP as its legal advisor. To read the full news, click here.

  Posted-In: Bank of America US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

• [By Sean Williams]

  Finally, Synergy Pharmaceuticals (NASDAQ: SGYP  ) may have had the wildest week of them all. Synergy's share price spiked 16% on Tuesday as an analyst at Cantor Fitzgerald raised her peak sales estimate for plecanatide, the company's midstage drug for chronic idiopathic constipation and irritable bowel syndrome with constipation, to $1.58 billion from $1.05 billion, as clinical data has been stronger than expected. However, the company didn't return the favor to shareholders by -- the very next day, mind you ��announcing a secondary offering of 16.375 million shares. The downside of clinical-stage companies is the always apparent risk of dilution. Shares have lost 25% since their Tuesday close.

Top Medical Stocks To Invest In Right Now: Organovo Holdings Inc (ONVO)

Organovo Holdings, Inc. (Organovo), formerly Real Estate Restoration & Rental, Inc., incorporated in 2007, is a development-stage company. The Company has developed and is commercializing a platform technology for the generation of three-dimensional (3D) human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. On December 28, 2011, Real Estate Restoration and Rental, Inc.�� (RERR) entered into an Agreement and Plan of Merger, pursuant to which RERR merged with its, wholly owned subsidiary, Organovo (Merger Sub). On February 8, 2012, the Company merged with and into Organovo Acquisition Corp. (Acquisition Corp.), a wholly owned subsidiary of Organovo, with the Company surviving the merger as a wholly owned subsidiary of Organovo Holdings (the Merger). As a result of the Merger, Organovo acquired the business of Organovo, Inc.

The Company has collaborative research agreements with Pfizer, Inc. (Pfizer) and United Therapeutic Corporation (Unither). As of March 31, 2012, it has five federal grants, including Small Business Innovation Research grants and developed the NovoGen MMX Bioprinter (its first-generation 3D bioprinter). The Company is engaged in the development of specific 3D human tissues to aid Pfizer in discovery of therapies in two areas of interest. In addition, in October 2011, it entered into a research agreement with Unither to establish and conduct a research program to discover treatments for pulmonary hypertension using its NovoGen MMX Bioprinter technology. Additionally, under the research agreement with Unither, the Company granted Unither an option to acquire from the Company a worldwide, royalty-bearing license in certain intellectual property created under the research agreement solely for use in the treatment or prevention of pulmonary hypertension and all other lung diseases.

The Company�� NovoGen MMX Bioprinter is an automate! d device that enables the fabrication of three-dimensional (3D) living tissues comprised of mammalian cells. A custom graphic user interface (GUI) facilitates the 3D design and execution of scripts that direct precision movement of the dispensing heads to deposit cellular building blocks (bio-ink) or supporting hydrogel. The Company is using a third party manufacturer, Invetech Pty., of Melbourne, Australia, to manufacture its NovoGen MMX Bioprinter. Its bioprinting technology and surrounding intellectual property and commercial rights serve as a platform for product generation across multiple markets that employ cell- and tissue-based products and services.

The Company competes with Organogenesis, Advanced BioHealing, Tengion, Genzyme, HumaCyte and Cytograft Tissue Engineering.

Advisors' Opinion:

• [By Bryan Murphy]

  At first glance, Organovo Holdings Inc. (NYSEMKT:ONVO) just looks like nothing more than a stock going through a bit of a volatile phase, spurred by a little more media attention than usual. The longer one looks at a chart of ONVO, however, the clearer it becomes this stock may have already started to break out and is now building up steam.

• [By Keith Fitz-Gerald]

  In the 4D medical world, Organovo Holdings Inc. (NYSE MKT: ONVO) appears to be off to a good start. They've got a number of bioprinting projects centered around functional human tissue, including a liver product that's planned for 2014. I believe the company will quickly branch into tumor modeling, transplantation, and pharma research.

• [By James E. Brumley]

  It's certainly not the way I would have likes for things to shake out with Organovo Holdings Inc. (NYSEMKT:ONVO), but I'm not going to complain - it's pointed in the right direction. More important, for anybody who's been wanting into an ONVO trade but wasn't sure where the right entry spot was, today's move is it, with just one little caveat.

Top Medical Stocks To Invest In Right Now: Cell Therapeutics Inc (CTIC)

Cell Therapeutics, Inc. (CTI), incorporated in 1991, develops, acquires and commercializes treatments for cancer. The Company�� research, development, acquisition and in-licensing activities concentrate on identifying and developing new ways to treat cancer. As of December 31, 2011, CTI focused its efforts on Pixuvri (pixantrone dimaleate) (Pixuvri), OPAXIO (paclitaxel poliglumex) (OPAXIO), tosedostat, brostallicin and bisplatinates. As of December 31, 2011, it developed Pixuvri, an anthracycline derivative for the treatment of hematologic malignancies and solid tumors. Another late-stage drug candidate of the Company, OPAXIO, is being studied as a potential maintenance therapy for women with advanced stage ovarian cancer, who achieve a complete remission following first-line therapy with paclitaxel and carboplatin. As of December 31, 2011, it also developed tosedostat in collaboration with Chroma Therapeutics, Ltd. (Chroma). On May 31, 2012, CTI completed its acquisition gaining worldwide rights to S*BIO Pte Ltd.'s (S*BIO) pacritinib.

Pixuvri

As of December 31, 2011, the Company developed Pixuvri, an aza-anthracenedione derivative, for the treatment of non-Hodgkin�� lymphoma (NHL), and various other hematologic malignancies, and solid tumors. Pixuvri was studied in the Company�� EXTEND, or PIX301, clinical trial, which was a phase III single-agent trial of Pixuvri for patients with relapsed, refractory aggressive NHL who received two or more prior therapies and who were sensitive to treatment with anthracyclines. On September 28, 2011, CTI announced that a second independent radiology assessment of response and progression endpoint data from its PIX301 clinical trial of Pixuvri was achieved with statistical significance. The results of the EXTEND trial met its primary endpoint and showed that patients randomized to treatment with Pixuvri achieved a significantly higher rate of confirmed and unconfirmed complete response compared to patients treated with standard chem! otherapy had a significantly increased overall response rate and experienced a statistically significant improvement in median progression free survival. Pixuvri had predictable and manageable toxicities when administered at the proposed dose and schedule in the EXTEND clinical trial in heavily pre-treated patients. In March 2011, the Company initiated the PIX-R trial to study Pixuvri in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Pixuvri has also been studied in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens. In the second quarter of 2010, the NCCTG opened this phase II study for enrollment. The study is closed to accrual and results are expected to be reported by the NCCTG later in 2012.

OPAXIO

OPAXIO is the Company�� biologically-enhanced chemotherapeutic agent that links paclitaxel to a biodegradable polyglutamate polymer, resulting in a new chemical entity. As of December 31, 2011, the Company focused its development of OPAXIO on ovarian, brain, esophageal, head and neck cancer. OPAXIO was designed to improve the delivery of paclitaxel to tumor tissue while protecting normal tissue from toxic side effects. In November 2010, results were presented by the Brown University Oncology Group from a phase II trial of OPAXIO combined with temozolomide (TMZ), and radiotherapy in patients with newly-diagnosed, high-grade gliomas, a type of brain cancer. The trial demonstrated a high rate of complete and partial responses and a high rate of six month progression free survival (PFS). Based on these results, the Brown University Oncology Group has initiated a randomized, multicenter, phase II study of OPAXIO and standard radiotherapy versus TMZ and radiotherapy for newly diagnosed patients with glioblastoma with an active gene termed MGMT that reduces responsiveness to TMZ. A phase I/II study of OPAXIO combined with radi! otherapy ! and cisplatin was initiated by SUNY Upstate Medical University, in patients with locally advanced head and neck cancer.

Tosedostat

In March 2011, the Company entered into a co-development and license agreement with Chroma Therapeutics, Ltd. (Chroma), providing the Company with marketing and co-development rights to Chroma�� drug candidate, tosedostat, in North, Central and South America. Tosedostat is an oral, aminopeptidase inhibitor that has demonstrated anti-tumor responses in blood related cancers and solid tumors in phase I-II clinical trials. Interim results from the phase II OPAL study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML) showed that once-daily, oral doses of tosedostat had predictable and manageable toxicities and results demonstrated response rates, including a high-response rate among patients who received prior hypomethylating agents, which are used to treat myelodysplastic syndrome (MDS), a precursor of AML.

Brostallicin

As of December 31, 2011, the Company developed brostallicin through its wholly owned subsidiary, Systems Medicine LLC, which holds rights to use, develop, import and export brostallicin. Brostallicin is a synthetic deoxyribonucleic acid (DNA) minor groove binding agent that has demonstrated anti-tumor activity and a favorable safety profile in clinical trials, in which more than 230 patients have been treated as of December 31, 2011. The Company uses a genomic-based platform to guide the development of brostallicin. A phase II study of brostallicin in relapsed, refractory soft tissue sarcoma met its predefined activity and safety hurdles and resulted in a first-line phase II clinical trial study that was conducted by the European Organization for Research and Treatment of Cancer (EORTC).

The Company competes with Bristol-Myers Squibb Company, Sanofi-Aventis, Pfizer, Roche Group, Genentech, Inc., Astellas Pharma, Eli Lilly and Company, Celgene, Telik, I! nc., TEVA! Pharmaceuticals Industries Ltd. and PharmaMar.

Advisors' Opinion:

• [By Nathalie Tadena]

  Among the companies with shares expected to actively trade in Friday’s session are Vanda Pharmaceuticals Inc.(VNDA), Kimberly-Clark(KMB) and Cell Therapeutics(CTIC).

• [By John Udovich]

  Large and small cap cancer stocks Gilead Sciences, Inc (NASDAQ: GILD), Celgene Corporation (NASDAQ: CELG), Veracyte (NASDAQ: VCYT), Genomic Health, Inc (NASDAQ: GHDX), Cell Therapeutics Inc (NASDAQ: CTIC) and MetaStat Inc (OTCMKTS: MTST) have all been producing a steady stream of news lately for biotech investors looking for a way to cash in on the growth in development of�cancer treatments. Just consider the following news:

• [By Bryan Murphy]

  Like it or not, all good things must come to an end.... even for a red hot stock like Cell Therapeutics Inc. (NASDAQ:CTIC). Yes, CTIC is up 111% since the end of 2013, up 14% today alone, and it doesn't look like the bulls have any reason to slow down now. That's exactly why now's the time for current shareholders to be afraid, however - expect it when you least expect it.

5 Best Canadian Stocks To Watch For 2014

Here are today's top news headlines from�Fool.com. Check back throughout the day as this list is updated, and follow us on Twitter at�TMFBreaking.

Autoliv to Build Chinese Textile Center

Sonoco Mulls Irish Plant Closure

KIMCO Sells Off Largest Non-Retail Part of Portfolio

Boeing Delivers First Canadian CH-147F Chinook

Alcoa to Close Smelter in Italy

Chicago Manufacturing Hits Four-Year Low

Tribune Co. Buying 19 TV Stations for $2.73 Billion

Intuit Selling Financial Services Business in $1.025 Billion Deal

iRobot Files Patent Infringement Lawsuit in Germany

Nokia Buying Siemens Out of Joint Venture for $2.23 Billion

Citigroup Settles With Fannie Mae for $968 Million

Chesapeake Energy Joint Venture With Sinopec Is in Business

Public Sector Boosts Construction Spending 0.5% for May

Oil States CEO to Serve on AT&T's Board of Directors

Neogen Acquires Veterinary Instrument Business

Top Industrial Conglomerate Stocks To Own Right Now: Aercap Holdings N.V. (AER)

AerCap Holdings N.V., through its subsidiaries, operates as an integrated aviation company worldwide. It engages in leasing and trading aircraft and engines; and selling parts. The company also provides aircraft management services, as well as aircraft and limited engine MRO services, and aircraft disassembly services through its repair stations. In addition, it offers aircraft services, including remarketing aircraft; collecting rental and maintenance payments, monitoring aircraft maintenance, monitoring and enforcing contract compliance, and accepting delivery and redelivery of aircraft; conducting ongoing lessee financial performance reviews; inspecting the leased aircraft; coordinating technical modifications to aircraft to meet new lessee requirements; conducting restructurings negotiations in connection with lease defaults; repossessing aircraft; arranging and monitoring insurance coverage; registering and de-registering aircraft; arranging for aircraft and aircraft engine valuations; and providing market research. The company?s management services include leasing and remarketing, cash management and treasury, technical advisory, and accounting and administrative services. As of March 31, 2011, it owned 272 aircraft and 95 engines, which it leased under operating leases to 118 lessees in 53 countries. The company was founded in 1995 and is headquartered in Schiphol, the Netherlands.

Advisors' Opinion:

• [By John Udovich]

  Yesterday around midday,�Netherlands based aviation leasing stock�AerCap Holdings N.V. (NYSE: AER) began surging on rumors and closed up 11.6%, meaning its probably time to take a closer look at those rumors along with aviation leasing peers like small caps or mid caps�Aircastle Limited (NYSE: AYR), Air Lease Corp (NYSE: AL), Fly Leasing Ltd (NYSE: FLY) and AeroCentury Corp (NYSEMKT: ACY).

• [By Roberto Pedone]

  AerCap (AER) provides aircraft leasing and aviation finance services. This stock closed up 3.3% at $18 in Wednesday's trading session.

  Wednesday's Volume: 740,000
  
  Three-Month Average Volume: 318,589
  
  Volume % Change: 85%

  From a technical perspective, AER jumped higher here right above its 50-day moving average of $17.27 with above-average volume. This stock has been uptrending strong for the last five months, with shares moving higher from its low of $14.84 to its recent high of $18.16. During that uptrend, shares of AER have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of AER within range of triggering a near-term breakout trade. That trade will hit if AER manages to take out its 52-week high at $18.16 with high volume.

  Traders should now look for long-biased trades in AER as long as it's trending above its 50-day at $17.27 or above more near-term support at $17.17 and then once it sustains a move or close above its 52-week high at $18.16 with volume that's near or above 318,589 shares. If that breakout hits soon, then AER will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $20 to $23.

5 Best Canadian Stocks To Watch For 2014: PennyMac Mortgage Investment Trust(PMT)

PennyMac Mortgage Investment Trust is based in the United States.

Advisors' Opinion:

• [By Jon C. Ogg]

  Sterne Agee’s team said, “We continue to prefer credit risk oriented Mortgage REITs over their Agency-only focused counterparts. Among the larger cap names in our coverage, our top picks are MFA Financial, Inc. (NYSE: MFA) and PennyMac Mortgage Investment Trust (NYSE: PMT).”

• [By Sally Jones] ng>Current Shares: 3,570,000

  Value: $80,968,000

  Weighting: 19.8%

  Down 9% over 12 months, PennyMac Mortgage Investment Trust, a residential REIT, has a market cap of $1.61 billion; its shares were traded at around $22.94 with a P/E of 7.30. The dividend yield is 10%.

  PMT is not ranked for business predictability.

  Track historical data:

  Guru Action: As of Sept. 30, 2013, Kyle Bass made a new buy of 3,570,000 shares at an average price of $21.84 per share, for a gain of 4.3%.

  The GuruFocus analysis of PMT shows five warning signs.

  Vodafone Group PLC (VOD)

  Current Shares: 1,349,200

  Value: $47,465,000

  Weighting: 11.6%

  Up 55% over 12 months, Vodafone Group PLC has a market cap of $189.2 billion; its shares were traded at around $39.14 with a P/E of 273.80. The dividend yield is 4.00%.

  Vodafone Group PLC is a provider of mobile communications services and products in Germany, Italy, Spain, UK, Europe, India and Africa, Middle East and Asia Pacific.

  GuruFocus ranked VOD with one out of five stars for business predictability.

  Track historical data:

  Guru Action: As of Sept. 30, 2013, Kyle Bass made a new buy of 1,349,200 shares at an average price of $31.01 per share, for a gain of 25.9%.

  The GuruFocus analysis of VOD shows nine warning signs.

  Microsoft Corporation (MSFT)

  Current Shares: 1,500,000

  Value: $49,920,000

  Weighting: 12.2%

  Up 38% over 12 months, Microsoft Corporation has a market cap of $309.54 billion; its shares were traded at around $37.45 with a P/E of 13.70. The dividend yield is 2.60%.

  GuruFocus ranked MSFT with three out of five stars for business predictability.

  Track historical data:

  Guru Action: As of Sept. 30, 2013, Kyle Bass made a new buy of 1,500,000 shares at an average price of $32.90 per share, for a gain of 12.7%.

  The GuruFocus analysis of MSFT shows two go

• [By Marc Bastow]

  PennyMac Mortgage Investment Trust (PMT), a REIT involved in mortgages and mortgage-related assets, raised its quarterly dividend 4% to 59 cents per share, payable Jan. 28 to shareholders of record as of Jan. 14. At more than 10%, PMT is the highest yielder of this week’s list of dividend stocks.
  PMT Stock Dividend Yield: 10.15%

5 Best Canadian Stocks To Watch For 2014: Iamgold Corporation(IAG)

IAMGOLD Corporation, together with its subsidiaries, engages in the exploration, development, and production of mineral resource properties worldwide. It primarily explores for gold, silver, zinc, copper, niobium, diamonds, and other metals. The company holds interests in eight operating gold mines, a niobium producer, a diamond royalty, and exploration and development projects located in Africa and the Americas. Its advanced exploration and development projects include the Westwood project in Canada; and the Quimsacocha project, which consists of 3 mining concessions covering an aggregate area of approximately 8,030 hectares in Ecuador. The company was formerly known as IAMGOLD International African Mining Gold Corporation and changed its name to IAMGOLD Corporation in June 1997. IAMGOLD Corporation was founded in 1990 and is based in Toronto, Canada.

Advisors' Opinion:

• [By Rich Duprey]

  IAMGOLD (NYSE: IAG  ) still has an interest in the�Quimsacocha gold mine it sold to INV Metals last year, which has an indicated mineral resource estimated at 3.3 million ounces gold. China's�Ecuacorriente is also pursing a major copper project at Panantza-San Carlos, and International Minerals will seek out gold and silver at Rio Blanco.

• [By Tom Stoukas]

  Air France led airlines lower, falling 4 percent to 7.30 euros. International Consolidated Airlines Group SA (IAG) lost 1.9 percent to 270.7 pence while Deutsche Lufthansa AG slid 2.1 percent to 15.75 euros.

• [By Namitha Jagadeesh]

  International Consolidated Airlines Group SA (IAG) and Air France-KLM (AF) Group rose with as a gauge of travel stocks as oil prices fell after Iran�� accord. PSA Peugeot Citroen gained 3.7 percent after people familiar with the matter said its chief executive officer plans to step down next year. Fresenius Medical Care AG surged the most in five years after U.S. regulators scrapped a plan to cut Medicare payments next year.

5 Best Canadian Stocks To Watch For 2014: Chipotle Mexican Grill Inc.(CMG)

Chipotle Mexican Grill, Inc. develops and operates fast-casual, fresh Mexican food restaurants in the United States, Canada, and England. Its restaurants primarily offer burritos, tacos, burrito bowls, and salads. As of December 31, 2011, it operated 1,230 restaurants, which includes 1 ShopHouse Southeast Asian Kitchen. Chipotle Mexican Grill, Inc. was founded in 1993 and is based in Denver, Colorado.

Advisors' Opinion:

• [By Ben Levisohn]

  Shares of Noodles & Co. have dropped 8% to $42.92 today at 11:47 a.m. Noodles is also dragging down other high-flying restaurant stocks. Potbelly (PBPB), for instance, has fallen 4.4% to $25.78, while Chipotle Mexican Grill (CMG) has declined 1.9% to $529.18 and Starbucks (SBUX) is off 1.5% at $79.92.

• [By WALLSTCHEATSHEET]

  Chipotle Mexican Grill provides consumers with quick, delicious, and healthy food options on a daily basis. The company recently delivered an earnings report that beat analyst expectations. The stock has been on a strong surge to higher prices and sees no signs of slowing just yet. Over the last four quarters, earnings and revenue figures have been increasing which has produced very pleased investors. Relative to its peers and sector, Chipotle Mexican Grill has been a year-to-date performance leader. Look for Chipotle Mexican Grill to continue to OUTPERFORM.

• [By Rich Bieglmeier]

  Chipotle Mexican Grill, Inc. (NYSE:CMG) could be tastier in the months to come according to Longbow Research. The firm upgraded the stock to a "Buy" from a "Neutral" recommendation.

Top India Stocks To Watch Right Now

If you are young and confused in money matters, don�� worry; help is at hand. We present five money management tips for young investors.

India�� ��oung��population is the topic of several discussions and debates. As this sizeable chunk of the population starts earning, it gives rise to higher disposable incomes, needs and aspirations.

Expectedly, managing money is a natural corollary. However, the youth as a segment, has its own set of needs and niceties. In keeping with the same, we present five money management tips for young investors.

1.  Say no to lazy money 

One of the biggest financial blunders is to leave money idle in a savings bank account. Sure, some banks have capitalised on the liberalised regime to offer higher rates than the norm, but that doesn�� justify leaving substantial monies in the bank account.

Instead, you should set aside enough money to meet your monthly expenses say for a 6-month period or thereabouts. In effect, this sum can be used to provide for any contingencies that may arise, and the balance monies should be invested.

10 Best China Stocks To Watch For 2015: Dr. Reddy's Laboratories Ltd(RDY)

Dr. Reddy?s Laboratories Limited, together with its subsidiaries, operates as a pharmaceutical company. It produces finished dosage forms, active pharmaceutical ingredients and intermediates, and biotechnology products. The company also conducts research in the areas of cancer, diabetes, cardiovascular, inflammation, and bacterial infection. In addition, it involves in the contract manufacture generic prescription and over-the-counter products for branded and generic companies in the United States. The company primarily focuses on therapeutic categories of cardiovascular, diabetes management, gastro-intestinal, and pain management. It markets its products in India, the United States, Europe, and the Russian Federation. The company has a co-development and commercialization agreement with Rheoscience A/S for the development and commercialization of Balaglitazone/DRF 2593, a partial PPAR-gamma agonist for the treatment of type 2 diabetes; an agreement with ClinTec Internatio nal for the development of an anti-cancer compound, DRF 1042; collaboration with the National Cancer Institute in Maryland; and an agreement with Argenta Discovery Limited for the joint development and commercialization of a novel approach to the treatment of chronic obstructive pulmonary disease. It also has an agreement with 7TM Pharma for drug discovery collaboration on selected drug targets; and an agreement with GlaxoSmithKline plc to develop and market pharmaceuticals for the treatment of cardiovascular disease, diabetes, oncology, gastroenterology, and pain management. Dr. Reddy?s Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.

Advisors' Opinion:

• [By Monica Gerson]

  Dr. Reddy's Laboratories (NYSE: RDY) is expected to report its Q4 earnings at $0.52 per share.

  YuMe (NYSE: YUME) is estimated to post a Q1 loss at $0.15 per share on revenue of $35.36 million.

Top India Stocks To Watch Right Now: Sify Technologies Limited(SIFY)

Sify Technologies Limited provides enterprise and consumer Internet services primarily in India. The company offers various corporate network/data services comprising e-commerce and network connectivity solutions, such as end-to-end services network, application, and security services; voice origination and termination services; co-location and managed hosting services; and system integration services for data centre build, hardware distribution, security solutions, and turnkey projects. It also provides application services, including SLEMS and Microsoft Exchange messaging platforms; I-test for online assessment and LiveWire, which enable management of training processes across the organization; document management system for the management of documents electronically; and Forum, a forward supply chain solution. In addition, the company operates e-Ports that offer browsing, chat, email, gaming, utility bill payment, travel ticketing, hotel booking, mobile recharge, Intern et telephony, and online share trading services; and portals, which provide news, views, reviews, interactions, and services in the areas of movies, sports, finance, food, videos, astrology, online games, shopping, and travel, as well as offers content offerings and broadband services. Further, it provides infrastructure management services, such as network management, datacenter and helpdesk outsourcing, desktop and storage outsourcing, IT security outsourcing, LAN and WAN outsourcing, database and telecom outsourcing, and application monitoring and management services to automotive, chemical, media, and financial enterprises; and virtualization design, integration, and deployment services for servers, storage, networks, and end user clients. Sify has approximately 1,278 e-Ports in 200 towns and cities; and serves 1,06,000 broadband subscribers through 1500 cable TV Operators. The company, formerly known as Sify Limited, was founded in 1995 and is based in Chennai, India. Advisors' Opinion:

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  Technology stocks gained Tuesday, with Ku6 Media Co (NASDAQ: KUTV) leading advancers. Among leading tech stocks, gains came from Rubicon Technology (NASDAQ: RBCN), Bitauto Holdings (NYSE: BITA) and Sify Technologies (NASDAQ: SIFY).

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  Technology stocks gained Tuesday, with Ku6 Media Co (NASDAQ: KUTV) leading advancers. Among leading tech stocks, gains came from Rubicon Technology (NASDAQ: RBCN), Bitauto Holdings (NYSE: BITA) and Sify Technologies (NASDAQ: SIFY). Utilities shares dropped by 0.11 percent in the US market today.

Top India Stocks To Watch Right Now: Tata Motors Ltd(TTM)

Tata Motors Limited, an automobile company, engages in the manufacture and sale of commercial and passenger vehicles primarily in India. The company offers cars, utility vehicles, trucks, buses and coaches, and defense vehicles, as well as develops electric and hybrid vehicles for personal and public transportation. It also involves in distributing and marketing cars; and financing the vehicles sold by the company. In addition, the company engages in the provision of engineering and automotive solutions, as well as machine tools and factory automation solutions; construction equipment manufacturing; automotive vehicle components manufacturing and supply chain activities; tooling and plastic and electronic components for automotive and computer applications; and automotive retailing and service operations. It offers its products and services through its dealership, sales, services, and spare parts network. The company also markets its commercial and passenger vehicles in Eu rope, Africa, the Middle East, South East Asia, South Asia, and South America. The company was formerly known as Tata Engineering and Locomotive Company Limited and changed its name to Tata Motors Limited in July 2003. Tata Motors Limited was founded in 1945 and is based in Mumbai, India.

Advisors' Opinion:

• [By Justin Loiseau]

  India and Australia just edged a little closer in the corporate car world. India's Tata Motors (NYSE: TTM  ) announced today that it will enter the Australian market under a new third-party distributor, M/s Fusion Automotive Pty Ltd. Australia.

Top India Stocks To Watch Right Now: Infosys Technologies Limited(INFY)

Infosys Ltd. provides information technology (IT) and consulting services worldwide. It offers IT services, such as application, architecture, independent validation and testing, information management, infrastructure, packaged application, SOA, systems integration, and knowledge services; product engineering services, manufacturing process and plant solutions, and product lifecycle management services; and consulting services in the areas of information and technology strategies, product innovation, next generation commerce, process excellence, and learning and complex change. The company also provides business process outsourcing solutions in the areas of business platforms, customer service outsourcing, finance and accounting, human resources outsourcing, legal services, sales and fulfillment, and sourcing and procurement outsourcing. In addition, it offers collaborative analytics solutions; digital consumer platform; Finacle universal banking solution; iProwe, a Web ac cessibility assessment product; mConnect, a real-time enterprise middleware; and research and analytical support services. Further, the company offers unified communications and collaboration solution that streamlines business processes between employees, customers, and suppliers; iTransform that helps healthcare organizations accelerate transition to new platforms; and supply chain visibility and collaboration product suite. It serves aerospace and defense, airlines, automotive, banking, capital markets, communication services, consumer packaged goods, manufacturing, education, energy, healthcare, high technology, hospitality and leisure, insurance, life sciences, logistics and distribution, publishing, resources, utilities, and retail industries. Infosys Ltd. has a strategic partnership with Alstom SA. The company was formerly known as Infosys Technologies Limited and changed its name to Infosys Ltd. on June 16, 2011. Infosys Ltd. was founded in 1981 and is headquartered i n Bengaluru, India.

Advisors' Opinion:

• [By Monica Gerson]

  Infosys (NASDAQ: INFY) is expected to report its Q2 earnings at $0.70 per share on revenue of $2.01 billion.

  Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

• [By Tim Brugger]

  Longtime Infosys (NYSE: INFY  ) CEO N.R. Narayana Murthy has returned to the company he founded in 1981 as its new executive chairman of the board, Infosys recently announced. The Infosys board approved the appointment, and his new role will now be "placed for the consideration of the company's shareholders" at the annual general meeting scheduled for June 15, according to the release.

• [By Laura Brodbeck]

  Next week investors will be waiting for several key earnings reports including Wells Fargo & Company (NYSE: WFC), Alcoa (NYSE: AA), Family Dollar Stores (NYSE: FDO) and Infosys Limited (NASDAQ: INFY).

Top India Stocks To Watch Right Now: Stewart Information Services Corporation(STC)

Stewart Information Services Corporation provides title insurance and related information services required for settlement by the real estate and mortgage industries. It operates in two segments, Title Insurance-Related Services and Real Estate Information. The Title Insurance-Related Services segment offers services that include searching for and examining documents, such as deeds, mortgages, wills, divorce decrees, court judgments, liens, paving assessments, and tax records, as well as provides titles insurance for residential and commercial properties, undeveloped acreage, farms, ranches, and water rights. This segment serves attorneys, builders, developers, home buyers and home sellers, lenders, and real estate brokers. The Real Estate Information segment offers products and services, which primarily include lender services, title technology, foreign and domestic government services, mapping, title information, Internal Revenue Code Section 1031 tax-deferred property e xchanges, pre-employment services, and online filing and transaction management. Its customers include mortgage lenders and servicers, mortgage brokers, mortgage investors, government entities, commercial and residential real estate agents, land developers, builders, title insurance agencies, and others interested in obtaining property information, as well as accountants, attorneys, investors, and employers. The company has operations primarily in the United States, Canada, the United Kingdom, central Europe, Mexico, central America, and Australia. Stewart Information Services Corporation was founded in 1893 and is based in Houston, Texas.

Advisors' Opinion:

• [By Ben Levisohn]

  Tower Group has dropped 12% to $3.88 today at 11:39 a.m., while Stewart Information Services (STC) has dipped 0.1% to $31.16, the�Navigators Group�(NAVG) has fallen 1.4% to $54.78 and HCI Group�(HCI) has gained 1% to $38.16.

• [By Ben Levisohn]

  Tower Group has dropped 40% to $4.43 today, and some other small insurers are also getting dinged this morning. HCI Group (HCI) has fallen 1.8% to $39.36, Stewart Information Services (STC) has declined 0.7% to $31.36 and the Navigators Group (NAVG) has ticked down 0.4% to $56.10.

• [By James Fink]

  My housing pick is Houston-based Stewart Information Services (STC), a 120-year-old real estate business founded in 1893, that is still owned and managed by the founding family.

Hot Asian Stocks For 2015

Hot Asian Stocks For 2015: The First of Long Island Corporation(FLIC)

The First of Long Island Corporation operates as a bank holding company for The First National Bank of Long Island that provides various financial services. It offers various deposit products, including checking, money market, savings, escrow service and interest on lawyer, time deposit, NOW, rent security, holiday club, and individual retirement accounts. The company?s loan portfolio consists of commercial and industrial loans; residential and commercial mortgage loans; home equity loans and lines; multifamily loans; construction loans; consumer loans, such as auto and home improvement loans, personal loans, overdraft checking lines, and credit cards; commercial loans, which include short-term business loans, term and installment loans, revolving credit term loans, and loans secured by marketable securities, general business assets, deposits, and surrender value of life insurance policies; and commercial and standby letters of credit. In addition, it provides account rec onciliation, ATM banking, bank by mail, bill payment, cash management, collection, drive-through banking, personal money orders, Internet and telephone banking, merchant credit card depository, lock box, night depository, payroll, remote deposit, securities transactions, signature guarantee, trust and investment management, wire transfers and foreign cables, and withholding tax depository services, as well as offers controlled disbursement accounts, travelers and counter checks, mutual funds, annuities, life insurance and securities, safe deposit boxes, and the U.S. savings bonds. Further, the company provides pension trust, personal trust, estate, and custody services; and insurance agency services, as well as owns a real estate investment trust. It offers its services to privately owned businesses, professionals, consumers, public bodies, and other organizations through its 34 br! anches primarily in Long Island and Manhattan. The company was founded in 1927 and is based in Glen Head, New York.

Advisors' Opinion:

• [By Dividends4Life]

  The First of Long Island Corporation (FLIC) operates as a bank holding company for The First National Bank of Long Island that provides financial services. Sept. 19, the company increased its quarterly dividend 4% to $0.26 per share. The dividend is payable Oct. 11, 2013 to shareholders of record on October 3, 2013. The yield based on the new payout is 2.7%.

source from Top Stocks For 2015:http://www.topstocksblog.com/hot-asian-stocks-for-2015.html